A research team led by Professor Jun Takahashi and Assistant Professor Asuka Morizane at the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, has carried out a study to compare the impact of ...
Sep 26, 2013
0
0
Both inactivated and live-attenuated vaccines generally produce an adequate immune response and are safe to use in children suffering with autoimmune diseases treated with all but the most potent immunosuppressants, according ...
Feb 2, 2021
0
11
(HealthDay)—COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests.
Jul 7, 2021
0
1
Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression of the immune system, ...
Mar 1, 2013
0
0
Columbia University Medical Center (CUMC) researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing ...
Mar 16, 2015
0
28
Maintenance immunosuppressive drugs are associated with an increased risk for COVID-19 hospitalization in solid organ transplant recipients, according to a study published online Nov. 7 in JAMA Network Open.
Nov 7, 2023
0
2
While waiting on the transplant list, most patients are extremely sick and fighting just to stay alive.
Jul 31, 2019
0
1
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
Feb 19, 2024
0
9
The immunosuppressive drug fingolimod (trade name: Gilenya) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform ...
Jul 5, 2012
0
0
Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades. To see what ...
Aug 28, 2019
0
0
